Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in Pharmacopsychiatry

Retrieve available abstracts of 25 articles:
HTML format



Single Articles


    May 2021
  1. SPOOV J, Bredbacka PE
    Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 microg i.v. TRH.
    Pharmacopsychiatry. 2021 May 12. doi: 10.1055/a-1481-9058.
    PubMed     Abstract available


    February 2021
  2. SHI H, Guan XN, Liu DY, Zhu L, et al
    Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study.
    Pharmacopsychiatry. 2021 Feb 24. doi: 10.1055/a-1353-6544.
    PubMed     Abstract available


    January 2021
  3. SAKURAI H, Yasui-Furukori N, Suzuki T, Uchida H, et al
    Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus.
    Pharmacopsychiatry. 2021 Jan 12. doi: 10.1055/a-1324-3517.
    PubMed     Abstract available


    December 2020
  4. GRUNDER G, Bauknecht P, Klingberg S, Leopold K, et al
    Treatment Goals for Patients with Schizophrenia - A Narrative Review of Physician and Patient Perspectives.
    Pharmacopsychiatry. 2020 Dec 8. doi: 10.1055/a-1298-4546.
    PubMed     Abstract available


    October 2020
  5. ZHANG T, Wang J, Xu L, Wei Y, et al
    Subtypes of Clinical High Risk for Psychosis that Predict Antipsychotic Effectiveness in Long-Term Remission.
    Pharmacopsychiatry. 2020 Oct 12. doi: 10.1055/a-1252-2942.
    PubMed     Abstract available


    August 2020
  6. WAGNER E, Oviedo-Salcedo T, Pelzer N, Strube W, et al
    Effects of Smoking Status on Remission and Metabolic and Cognitive Outcomes in Schizophrenia Patients Treated with Clozapine.
    Pharmacopsychiatry. 2020 Aug 5. doi: 10.1055/a-1208-0045.
    PubMed     Abstract available


    July 2020

  7. "Peter Muller Preis fur Forschung im Bereich Schizophrenie" in Hohe von 5.000euro.
    Pharmacopsychiatry. 2020;53:194.
    PubMed     Abstract available


    January 2020
  8. KISHI T, Yoshimura R, Matsuda Y, Sakuma K, et al
    Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan.
    Pharmacopsychiatry. 2020 Jan 30. doi: 10.1055/a-1096-1266.
    PubMed     Abstract available


    August 2019
  9. SCHAEFER M, Sarkar S, Theophil I, Leopold K, et al
    Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
    Pharmacopsychiatry. 2019 Aug 7. doi: 10.1055/a-0970-9310.
    PubMed     Abstract available


  10. BARTSCH JC, Schott BH, Behr J
    Hippocampal Dysfunction in Schizophrenia and Aberrant Hippocampal Synaptic Plasticity in Rodent Model Psychosis: a Selective Review.
    Pharmacopsychiatry. 2019 Aug 1. doi: 10.1055/a-0960-9846.
    PubMed     Abstract available


    July 2019
  11. SCHENNACH R, Riedel M, Spellmann I, Musil R, et al
    Correction: Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
    Pharmacopsychiatry. 2019;52:e1.
    PubMed    


    June 2019
  12. ZHENG W, Li XB, Shi ZM, Yang XH, et al
    Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
    Pharmacopsychiatry. 2019 Jun 17. doi: 10.1055/a-0914-3260.
    PubMed     Abstract available


    January 2019
  13. TASMIM S, Kolla NJ, Dada O, Bani-Fatemi A, et al
    Correlation Between Violence and Antipsychotic Dosage in Schizophrenia: A Secondary Analysis of The Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE) Dataset.
    Pharmacopsychiatry. 2019 Jan 22. doi: 10.1055/a-0826-4935.
    PubMed     Abstract available


  14. ZHENG W, Zhang QE, Cai DB, Yang XH, et al
    Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials.
    Pharmacopsychiatry. 2019;52:24-31.
    PubMed     Abstract available


    September 2018
  15. SCHENNACH R, Riedel M, Spellmann I, Musil R, et al
    Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
    Pharmacopsychiatry. 2018 Sep 20. doi: 10.1055/a-0669-9461.
    PubMed     Abstract available


    July 2018
  16. OLIVEIRA P, Coroa M, Madeira N
    Treatment Options for Insomnia in Schizophrenia: A Systematic Review.
    Pharmacopsychiatry. 2018 Jul 30. doi: 10.1055/a-0658-1645.
    PubMed     Abstract available


  17. KROC A, Debicka M, Wierzbicka A, Wolkow L, et al
    Sertindole: EEG Analysis, Tolerability, and Clinical Efficacy.
    Pharmacopsychiatry. 2018;51:144-147.
    PubMed     Abstract available


    May 2018
  18. YOSHIDA K, Uchida H, Suzuki T, Watanabe M, et al
    Prediction Model of Serum Lithium Concentrations.
    Pharmacopsychiatry. 2018;51:82-88.
    PubMed     Abstract available


    March 2018
  19. KISHI T, Matsui Y, Matsuda Y, Katsuki A, et al
    Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pharmacopsychiatry. 2018 Mar 7. doi: 10.1055/a-0574-0088.
    PubMed     Abstract available


  20. ROSER P, Pichler EM, Habermeyer B, Kawohl W, et al
    Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients.
    Pharmacopsychiatry. 2018 Mar 5. doi: 10.1055/a-0573-9866.
    PubMed     Abstract available


    January 2018
  21. DEMBLER-STAMM T, Fiebig J, Heinz A, Gallinat J, et al
    Sexual Dysfunction in Unmedicated Patients with Schizophrenia and in Healthy Controls.
    Pharmacopsychiatry. 2018 Jan 29. doi: 10.1055/s-0044-100627.
    PubMed     Abstract available


    July 2017
  22. LI XB, Zheng W, Ning YP, Cai DB, et al
    Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review.
    Pharmacopsychiatry. 2017 Jul 17. doi: 10.1055/s-0043-114670.
    PubMed     Abstract available


  23. NAGAI N, Tani H, Suzuki T, Ikai S, et al
    Patients' Knowledge about Prescribed Antipsychotics and Medication Adherence in Schizophrenia: A Cross-Sectional Survey.
    Pharmacopsychiatry. 2017 Jul 4. doi: 10.1055/s-0043-113828.
    PubMed     Abstract available


  24. MAURI MC, Paletta S, Di Pace C, Reggiori A, et al
    Paliperidone Long-Acting Plasma Level Monitoring and a New Method of Evaluation of Clinical Stability.
    Pharmacopsychiatry. 2017;50:145-151.
    PubMed     Abstract available


    May 2017
  25. SCHENNACH R, Obermeier M, Seemuller F, Jager M, et al
    Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?
    Pharmacopsychiatry. 2017 May 15. doi: 10.1055/s-0043-106436.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: